Dr. Dhanji Rajani | Immunology and Microbiology | Best Researcher Award

Microbiologist at Microcare laboratory and Tuberculosis research centre, India

Dr. Dhanji Popatbhai Rajani is a distinguished microbiologist with nearly two decades of experience in medical microbiology and diagnostics. He has made significant contributions to tuberculosis (TB) research, including evaluating innovative PCR tests for MDR TB and developing non-invasive, low-cost rapid diagnostics under prestigious government-funded projects like IMPRINT. With over 106 research publications and 24 patents, his work spans green synthesis, drug discovery, and sustainable methodologies. Dr. Rajani has received accolades such as the Best Performance Award for TB diagnosis from Surat Municipal Corporation in 2015 and 2016, highlighting his impact on public health. Currently leading diagnostics at Microcare Lab & TRC, he combines clinical expertise with research innovation. His leadership roles and commitment to advancing microbiology through cutting-edge research, sustainable practices, and impactful diagnostics establish him as a leading figure in his field, making him an exceptional candidate for recognition like the Best Researcher Award.

Professional Profile 

• Google Scholar
• Scopus Profile
• ORCID Profile

Education

Professional Experience

Dr. Dhanji Popatbhai Rajani has an extensive professional career in microbiology, marked by leadership roles and impactful contributions to clinical diagnostics. Since 2004, he has served as a Microbiologist at Microcare Lab & TRC, where he has led diagnostic and research initiatives, particularly in tuberculosis (TB) and other infectious diseases. From 2009 to 2013, he was the Chief Microbiologist at Smt. R. B. Shah Mahavir Hospital, where he spearheaded clinical diagnostic services and strengthened laboratory operations. With nearly two decades of experience, Dr. Rajani has established himself as a leader in medical microbiology, combining hands-on diagnostic expertise with cutting-edge research. His work has not only advanced TB diagnostics but also contributed to sustainable and innovative practices in microbiology. Dr. Rajani’s professional journey reflects a blend of clinical excellence, research innovation, and leadership, making him a pivotal figure in his field.

Research Interest

Dr. Dhanji Popatbhai Rajani’s research interests lie at the intersection of medical microbiology, innovative diagnostics, and sustainable scientific methodologies. He is deeply committed to advancing tuberculosis (TB) diagnostics, focusing on developing non-invasive, cost-effective, and rapid diagnostic tools that address global health challenges. His work also includes exploring green synthesis methods, such as using natural catalysts, to create sustainable and environmentally friendly processes in drug development. Dr. Rajani’s research encompasses the design and biological evaluation of novel compounds with antifungal, antimalarial, and antitubercular properties, integrating advanced techniques like molecular docking, ADME-Tox analysis, and pharmacophore modeling. With a keen interest in sustainable innovations, he has also contributed to the synthesis of bioactive compounds using eco-friendly methods. Dr. Rajani’s multidisciplinary approach reflects his commitment to improving public health through groundbreaking research and sustainable solutions, positioning him as a leader in medical microbiology and diagnostics.

Award and Honor

Dr. Dhanji Popatbhai Rajani has been recognized for his outstanding contributions to medical microbiology and diagnostics through several prestigious awards and honors. He received the Best Performance Award for TB diagnosis from the Surat Municipal Corporation in both 2015 and 2016, acknowledging his excellence in advancing tuberculosis diagnostics and public health impact. These accolades highlight his dedication to combating TB through innovative diagnostic solutions and his commitment to improving healthcare outcomes. Dr. Rajani’s work has garnered widespread appreciation for its relevance and effectiveness in addressing critical challenges in infectious disease management. These honors underscore his ability to translate research into practical applications, benefiting communities and setting new standards in diagnostic microbiology. With his achievements and consistent recognition, Dr. Rajani has established himself as a leading figure in his field, making significant strides in medical innovation and public health.

Conclusion

Dr. Dhanji Popatbhai Rajani is a strong candidate for the Best Researcher Award due to his extensive contributions to medical microbiology, particularly in TB diagnostics and drug synthesis. His robust portfolio of research papers, patents, and awards, combined with leadership in impactful projects, underscores his eligibility. Strengthening international collaboration and diversifying research impact would further elevate his profile for future recognition.

Publications Top Noted

• Title: Synthesis of benzimidazolyl-1, 3, 4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents
  Authors: RV Patel, PK Patel, P Kumari, DP Rajani, KH Chikhalia
  Year: 2012
  Citation: 191
• Title: Synthesis and identification of β-aryloxyquinolines and their pyrano [3, 2-c] chromene derivatives as a new class of antimicrobial and antituberculosis agents
  Authors: DC Mungra, MP Patel, DP Rajani, RG Patel
  Year: 2011
  Citation: 161
• Title: A strategic approach to the synthesis of functionalized spirooxindole pyrrolidine derivatives: in vitro antibacterial, antifungal, antimalarial and antitubercular studies
  Authors: S Haddad, S Boudriga, TN Akhaja, JP Raval, F Porzio, A Soldera, M Askri, DP Rajani
  Year: 2015
  Citation: 112
• Title: Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial agents
  Authors: RV Patel, P Kumari, DP Rajani, KH Chikhalia
  Year: 2011
  Citation: 109
• Title: Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl/benzothiazolyl acetamides as antimicrobial and antituberculosis agents
  Authors: RV Patel, P Kumari, DP Rajani, KH Chikhalia
  Year: 2013
  Citation: 105
• Title: Antimicrobial, Anti-TB, Anticancer and Anti-HIV Evaluation of New s-Triazine-Based Heterocycles
  Authors: RV Patel, P Kumari, DP Rajani, C Pannecouque, E De Clercq, KH Chikhalia
  Year: 2012
  Citation: 79
• Title: New 2-benzylsulfanyl-nicotinic acid based 1, 3, 4-oxadiazoles: Their synthesis and biological evaluation
  Authors: NB Patel, AC Purohit, DP Rajani, R Moo-Puc, G Rivera
  Year: 2013
  Citation: 76
• Title: Hydroxyl alkyl ammonium ionic liquid assisted green and one-pot regioselective access to functionalized pyrazolodihydropyridine core and their pharmacological evaluation
  Authors: DM Patel, MG Sharma, RM Vala, I Lagunes, A Puerta, JM Padrón, DP Rajani
  Year: 2019
  Citation: 72
• Title: Synthesis, characterization and pharmacological activities of 2-[4-cyano-(3-trifluoromethyl) phenyl amino)]-4-(4-quinoline/coumarin-4-yloxy)-6-(fluoropiperazinyl)-s-triazines
  Authors: RV Patel, P Kumari, DP Rajani, KH Chikhalia
  Year: 2011
  Citation: 68
• Title: A Practical Green Visit to the Functionalized [1,2,4]Triazolo[5,1‐b]quinazolin‐8(4H)one Scaffolds Using the Group‐Assisted Purification (GAP) Chemistry and Their Biological Evaluation
  Authors: DM Patel, RM Vala, MG Sharma, DP Rajani, HM Patel
  Year: 2019
  Citation: 65
• Title: Synthesis and evaluation of new chalcones, derived pyrazoline and cyclohexenone derivatives as potent antimicrobial, antitubercular and antileishmanial agents
  Authors: V Monga, K Goyal, M Steindel, M Malhotra, DP Rajani, SD Rajani
  Year: 2014
  Citation: 64
• Title: Green approach for synthesis of bioactive Hantzsch 1, 4-dihydropyridine derivatives based on thiophene moiety via multicomponent reaction
  Authors: MG Sharma, DP Rajani, HM Patel
  Year: 2017
  Citation: 57